Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZW) Depreciation & Amortization (CF) (2021 - 2025)

Core Scientific (CORZW) has disclosed Depreciation & Amortization (CF) for 5 consecutive years, with $14.1 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 45.87% to $14.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $68.9 million through Dec 2025, down 39.13% year-over-year, with the annual reading at $68.9 million for FY2025, 39.13% down from the prior year.
  • Depreciation & Amortization (CF) hit $14.1 million in Q4 2025 for Core Scientific, down from $16.3 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $68.7 million in Q4 2022 to a low of $2.9 million in Q1 2021.
  • Historically, Depreciation & Amortization (CF) has averaged $26.8 million across 5 years, with a median of $22.4 million in 2021.
  • Biggest five-year swings in Depreciation & Amortization (CF): surged 1520.65% in 2022 and later plummeted 62.47% in 2023.
  • Year by year, Depreciation & Amortization (CF) stood at $20.5 million in 2021, then surged by 235.59% to $68.7 million in 2022, then tumbled by 54.59% to $31.2 million in 2023, then dropped by 16.54% to $26.0 million in 2024, then plummeted by 45.87% to $14.1 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for CORZW at $14.1 million in Q4 2025, $16.3 million in Q3 2025, and $18.8 million in Q2 2025.